Aquestive Therapeutics, Inc. (NASDAQ:AQST - Get Free Report) CEO Daniel Barber sold 25,000 shares of the business's stock in a transaction on Thursday, October 15th. The shares were sold at an average price of $4.22, for a total transaction of $105,500.00. Following the transaction, the chief executive officer owned 627,317 shares in the company, valued at approximately $2,647,277.74. This represents a 3.83% decrease in their ownership of the st…
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.